Supplementary Figure S2 from A Novel Anti-CD47 Antibody TJH2201: Efficacious Tumor Suppression with Reduced RBC Toxicity via a SIRPα-Independent Mechanism
Abstract
Supplementary Figure S2: Binding ability and in vitro human RBC agglutination assay of Hu5F9/gp120.
Fields of Study & Subjects
Phagocytosis and Immune Regulation
Chemokine receptors and signaling
Erythrocyte Function and Pathophysiology
Publication details
- Publisher
- American Association for Cancer Research (AACR)
- Publication date
- 2 January 2026